Ikki Sakuma

553 citations
30 papers · 301 indexed · h-index 11

Ikki Sakuma

25 papers receiving 298 citations

Peers

Ikki Sakuma
Comparison fields: 5 of 61
  • Endocrinology, Diabetes and Metabolism 110
  • Surgery 96
  • Molecular Biology 86
  • Epidemiology 62
  • Cancer Research 50
Replace Hui‐Pin Hsiao with:
Hui‐Pin Hsiao Taiwan
Irene Andrés‐Blasco Spain
Xinbo Zhang United States
Mohsen Fathzadeh United States
Felipe Crispim Brazil
Sinan Tanyolaç Türkiye
Amirfarbod Yazdanyar United States
Jessica Smith United Kingdom
Takatoshi Anno Japan
Qiaoqing Zhong China
Ikki Sakuma relative to Hui‐Pin Hsiao Taiwan Hui‐Pin Hsiao's profile →
Citations per field
00.5×3.7×
Hui‐Pin Hsiao · 1×
Citations per year

Countries citing papers authored by Ikki Sakuma

Since Specialization
Citations

This map shows the geographic impact of Ikki Sakuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ikki Sakuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ikki Sakuma more than expected).

Fields of papers citing papers by Ikki Sakuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ikki Sakuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ikki Sakuma. The network helps show where Ikki Sakuma may publish in the future.

Co-authorship network of co-authors of Ikki Sakuma

This figure shows the co-authorship network connecting the top 25 collaborators of Ikki Sakuma. A scholar is included among the top collaborators of Ikki Sakuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ikki Sakuma. Ikki Sakuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 11
5 2
6 1
7 36
8 10
9 4
10 9
11 14
12 21
13 11
14 46
15 9
16 5
17 31
18 6
19 2
20
[Two cases of methanol poisoning with chronological measurements of blood concentrations of methanol, ethanol and formate].
3

About Ikki Sakuma

Ikki Sakuma is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Cell Biology, having authored 30 papers that have together received 301 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (6 papers), Adrenal and Paraganglionic Tumors (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (110 citations), Cancer Research (50 citations) and Surgery (96 citations). Ikki Sakuma has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Tomoaki Tanaka, Hidekazu Nagano, Koutaro Yokote, Akitoshi Nakayama, Naoko Hashimoto, Sawako Suzuki, Masanori Fujimoto, Hironobu Sasano, Mario Kahn and Ichiro Tatsuno. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026